A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

Clinical trial NCT06072781 · RECRUITING

Trial details

NCT number: NCT06072781
Sponsor: Verastem, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Low Grade Serous Ovarian Cancer

Start date: 2024-03-18
Primary completion: 2028-10-15
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.